Aspergo Labs Publishes Results on First Oral Spray for ED

Aspergo Labs released a Phase 1 Study proving the efficacy of their oral spray for erectile dysfunction, revealing that this new product absorbs within 5 minutes: twice as fast as existing sildenafil tablets. Read the full press release on Exec Edge today.

Previous
Previous

Authentrics.AI and Safire selected for Innov865 Pitch Competition

Next
Next

Sparkz wins $15M from CAEATFA